Feed - News and features

• Novo Nordisk leaps on new obesity drug data
  Shares in Novo Nordisk have risen...
• Neko Health raises $260m for its bid to transform healthcare
  Spotify founder Daniel Ek's new...
• AstraZeneca reveals $570m investment in Canada
  AstraZeneca has announced another...
• UnitedHealth names CEO to replace slain Thompson
  UnitedHealth has appointed company...

News | PharmaTimes

• Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment
• Tris Pharma announces positive results from ALLEVIATE-1 trial of cebranopadol
• Innovative Health Initiative launches a trial aimed at ending Crohn’s Disease
• AstraZeneca receives positive recommendations for lung cancer treatments
• AlzeCure’s NeuroRestore ACD856 to be presented at AD/PD 2025

• Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
• Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
• Computer-guided Versus Conventional Eminectomy
• Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms